Anna S. Berghoff

14.7k total citations · 2 hit papers
292 papers, 7.4k citations indexed

About

Anna S. Berghoff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Anna S. Berghoff has authored 292 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Oncology, 149 papers in Pulmonary and Respiratory Medicine and 87 papers in Genetics. Recurrent topics in Anna S. Berghoff's work include Brain Metastases and Treatment (124 papers), Glioma Diagnosis and Treatment (84 papers) and Lung Cancer Research Studies (62 papers). Anna S. Berghoff is often cited by papers focused on Brain Metastases and Treatment (124 papers), Glioma Diagnosis and Treatment (84 papers) and Lung Cancer Research Studies (62 papers). Anna S. Berghoff collaborates with scholars based in Austria, Germany and United States. Anna S. Berghoff's co-authors include Matthias Preusser, Georg Widhalm, Peter Birner, Rupert Bartsch, Karin Dieckmann, Christoph Zielinski, Johannes A. Hainfellner, Orsolya Rajky, Adelheid Wöhrer and Angelika M. Starzer and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Anna S. Berghoff

272 papers receiving 7.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

2014 445 citations Anna S. Berghoff, Barbara Kiesel et al. Neuro-Oncology profile →
Quantitative evidence for early metastatic seeding in colorectal cancer

2019 289 citations Anna S. Berghoff, Matthias Preusser et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anna S. Berghoff	3.8k	3.2k	2.2k	1.6k	975	292	7.4k
Serge Leyvraz	3.4k 0.9×	3.2k 1.0×	1.4k 0.7×	1.9k 1.2×	1.0k 1.0×	214	8.5k
Xiaobu Ye	2.6k 0.7×	1.4k 0.4×	2.3k 1.1×	1.3k 0.8×	1.2k 1.3×	151	6.8k
Manmeet S. Ahluwalia	3.8k 1.0×	4.4k 1.4×	4.6k 2.1×	1.9k 1.2×	1.4k 1.4×	398	9.6k
Karin Dieckmann	2.2k 0.6×	3.1k 1.0×	2.0k 0.9×	782 0.5×	411 0.4×	216	6.5k
Peter Birner	4.0k 1.1×	2.1k 0.7×	1.1k 0.5×	3.3k 2.1×	1.2k 1.2×	169	9.0k
Wei Qiao	2.7k 0.7×	1.3k 0.4×	931 0.4×	1.4k 0.9×	1.3k 1.3×	162	5.7k
Shouhao Zhou	4.5k 1.2×	1.3k 0.4×	1.1k 0.5×	1.1k 0.7×	918 0.9×	162	7.9k
Vittorina Zagonel	5.3k 1.4×	2.4k 0.8×	2.3k 1.0×	2.0k 1.3×	1.2k 1.2×	467	11.4k
Joohyuk Sohn	7.9k 2.1×	5.6k 1.7×	1.3k 0.6×	1.8k 1.2×	666 0.7×	303	10.9k
Maurizio Martini	1.9k 0.5×	1.1k 0.3×	1.3k 0.6×	2.3k 1.5×	614 0.6×	281	6.5k

Countries citing papers authored by Anna S. Berghoff

Since Specialization

Citations

This map shows the geographic impact of Anna S. Berghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna S. Berghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna S. Berghoff more than expected).

Fields of papers citing papers by Anna S. Berghoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna S. Berghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna S. Berghoff. The network helps show where Anna S. Berghoff may publish in the future.

Co-authorship network of co-authors of Anna S. Berghoff

This figure shows the co-authorship network connecting the top 25 collaborators of Anna S. Berghoff. A scholar is included among the top collaborators of Anna S. Berghoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna S. Berghoff. Anna S. Berghoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomasich, Erwin, Maximilian J. Mair, Ariane Steindl, et al.. (2024). 450MO Characterization of tumor-infiltrating lymphocytes and tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases. Annals of Oncology. 35. S409–S410.

Berger, J.M., Erwin Tomasich, M. Korpan, et al.. (2024). 23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response. Immuno-Oncology Technology. 24. 100905–100905. 1 indexed citations

Moik, Florian, Daniel Steiner, Angelika M. Starzer, et al.. (2024). Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study. Blood. 144(22). 2349–2359. 12 indexed citations

Berger, J.M., Matthias Preusser, Anna S. Berghoff, & Elisabeth Bergen. (2023). Malignant ascites: Current therapy options and treatment prospects. Cancer Treatment Reviews. 121. 102646–102646. 14 indexed citations

Berger, J.M., Rainer Puhr, Bernhard Scheiner, et al.. (2023). Clinical risk factors for ascites in metastatic pancreatic cancer. ESMO Open. 8(2). 101200–101200. 5 indexed citations

Steindl, Ariane, Arne Kienzle, Erwin Tomasich, et al.. (2023). 537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases. Annals of Oncology. 34. S405–S405. 1 indexed citations

Mair, Maximilian J., Rainer Puhr, Marlene Troch, et al.. (2023). Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. Infectious Agents and Cancer. 18(1). 9–9. 1 indexed citations

Mair, Maximilian J., Rupert Bartsch, Émilie Le Rhun, et al.. (2023). Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours. Nature Reviews Clinical Oncology. 20(6). 372–389. 45 indexed citations

Tomasich, Erwin, Ariane Steindl, Rainer Puhr, et al.. (2023). Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. Clinical Cancer Research. 29(16). 3225–3236. 14 indexed citations

10.

Mair, Maximilian J., Gerwin Heller, Rainer Puhr, et al.. (2022). Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. Clinical Cancer Research. 28(20). 4565–4573. 8 indexed citations

11.

Garrido, Pilar, et al.. (2021). Gender equality in oncology The importance of representation.

12.

Kiesel, Barbara, Lisa I. Wadiura, Mario Mischkulnig, et al.. (2021). Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years. Cancers. 13(23). 6119–6119. 7 indexed citations

13.

Hosmann, Arthur, Matthias Millesi, Lisa I. Wadiura, et al.. (2021). Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”. Cancers. 13(22). 5705–5705. 4 indexed citations

14.

Hosmann, Arthur, Matthias Millesi, Lisa I. Wadiura, et al.. (2021). 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers. 13(11). 2540–2540. 28 indexed citations

15.

Rhun, Émilie Le, Patrick Devos, Johannes Weller, et al.. (2020). Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncology. 23(7). 1100–1112. 69 indexed citations

16.

Berghoff, Anna S., Angelika M. Starzer, Nicolás Ballarini, et al.. (2020). Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer. European Journal of Cancer. 135. 150–158. 12 indexed citations

17.

Bergen, Elisabeth, Anna S. Berghoff, Margaretha Rudas, et al.. (2019). Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases. Clinical Cancer Research. 25(9). 2737–2744. 33 indexed citations

18.

Yang, Dian, Sarah K. Denny, Peyton Greenside, et al.. (2018). Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin. Cancer Discovery. 8(10). 1316–1331. 104 indexed citations

19.

Osswald, Matthias, Jonas Blaes, Yunxiang Liao, et al.. (2016). Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases. Clinical Cancer Research. 22(24). 6078–6087. 88 indexed citations

20.

Berghoff, Anna S., Vyshak Alva Venur, Matthias Preusser, & Manmeet S. Ahluwalia. (2016). Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment. American Society of Clinical Oncology Educational Book. 35(36). e116–e122. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact